|
Tumor site
|
Patients (nb)
|
Ipsilateral PG
|
Contralateral PG
|
Ipsilateral SMG
|
Contralateral SMG
|
OC
|
|---|
| | |
No. of spared glands
|
Mean dose Gy (range)
|
No. of spared glands
|
Mean dose Gy (range)
|
No. of spared glands
|
Mean dose Gy (range)
|
No. of spared glands
|
Mean dose Gy (range)
|
Nb
|
Mean dose Gy (range)
|
|---|
|
Oral cavity
|
8
|
5
|
31 (29.4-32.5)
|
8
|
27.1 (16–31.7)
|
NS
|
NA
|
NS
|
NA
|
NS
|
NA
|
|
Oropharynx
|
31
|
12
|
28.6 (25–31.5)
|
30
|
27.5 (23.6-32.2)
|
2
|
35.5 (33–38)
|
8
|
33.8 (29–36.5)
|
5
|
34.2 (29.7-38.2)
|
|
Hypopharynx
|
17
|
9
|
28.9 (24.4-31.5)
|
17
|
27.6 (22.9-34.4)
|
1
|
39.6
|
4
|
36.1 (28.7-39.5)
|
9
|
34.8 (30.5-40)
|
|
Larynx
|
10
|
9
|
26.8 (20.7-33.2)
|
10
|
25 (19.1-30.1)
|
1
|
34.9
|
3
|
36.7 (34–39)
|
9
|
30.5 (23–39.7)
|
|
Nasopharynx
|
3
|
2
|
30.2 (30.4-30)
|
3
|
27.8 (26.7-28.7)
|
1
|
38
|
2
|
33.1 (30.3-35.8)
|
3
|
33.5 (29.7-35.2)
|
|
Unknown primary
|
1
|
1
|
32.5
|
1
|
17.3
|
NS
|
NA
|
1
|
28
|
1
|
44.3
|
- Abbreviations: PG parotid gland; SMG submandibular gland; OC oral cavity; NS Non spared; NA Non applicable.
